RxDoctor Payments Data

Kelly Colbert

Family · Pueblo, CONPI 1487838207

Payments from drug & device makers

$608in general payments, 2019–2025

Across 34 payments — averaging $17.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$156
  • Novo Nordisk$129
  • Pfizer$95
  • Idorsia Pharmaceuticals US Inc$57
  • Biohaven Pharmaceuticals, Inc.$53
  • Abbott$24
  • plus $94 from 6 others

What the payments were for

  • Food & beverage$608100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$608 in reported general payments places this provider in the 70th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$24,676
Medicare patients
73
Services billed
375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide82$96,243
FarxigaDapagliflozin Propanediol49$48,571
OzempicSemaglutide12$13,768
Rosuvastatin Calcium82$1,340
Ezetimibe26$1,092
Pregabalin36$898
Levothyroxine Sodium89$606
Atorvastatin Calcium64$595
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst35$514
Losartan Potassium50$489
Bupropion XlBupropion Hcl14$454
Metformin Hcl38$429
Gabapentin24$380
Omeprazole30$361
Duloxetine Hcl15$280

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$13$96,24382 claims
AstraZenecaFarxiga$156$48,57149 claims
Novo NordiskOzempic$129$13,76812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,182 family providers in Colorado.

Other family in Pueblo

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →